The present invention is directed to polymerizable dental compositions containing a) 3 to 80 wt. % of cycloaliphatic epoxides; b) 0 to 80 wt. % of an epoxide or a mixture of epoxides which are different from a); c) 3 to 85 wt. % of a filer material; d) 0.01 to 25 wt. % of initiators, inhibitors and/or accelerators; e) 0 to 25 wt. % of auxiliary agents, the individual percentages of which are in relation to the total weight. The new polymerizable agents are particularly suited as dental material.
|
1. Polymerizable dental composition comprising
(a) 3 to 80 wt. % of an epoxide or a mixture of epoxides of the general formula: ##STR34## in which, for type A: if n=2 Z denotes a cycloaliphatic or aromatic radical having 1 to 22 carbon atoms or a combination of these radicals, wherein one or more carbon atoms can be replaced by o, C═O, --o(C═O)--, SiR2 and/or NR, or an aliphatic radical having 0 to 22 carbon atoms, wherein one or more carbon atoms can be replaced by o, C═O, --o(C═O)--, NR or SiR2, wherein at least one carbon atom must be replaced by SiR2, and wherein R is an aliphatic radical having 1 to 7 carbon atoms, wherein one or more carbon atoms can be replaced by o, C═O and/or --o(O═O)--, if n>2 Z denotes an aliphatic, cycloaliphatic or aromatic radical having 0 to 22 carbon atoms or a combination of these radicals, wherein one or more carbon atoms can be replaced by o, C═O, --o(C═O)--, SiR2 and/or NR and wherein R is an aliphatic radical having 1 to 7 carbon atoms, wherein one or more carbon atoms can be replaced by o, C═O and/or --o(C═O)--, and in which, for type b: Z denotes an aliphatic, cycloaliphatic or aromatic radical having 0 to 22 carbon atoms or a combination of these radicals, wherein one or more carbon atoms can be replaced by o, C═O, --o(C═O)--, SiR2 and/or NR and wherein R is an aliphatic radical having 1 to 7 carbon atoms, wherein one or more carbon atoms can be replaced by o, C═O and/or --o(C═O)--, and in which, for type A and type b: A denotes an aliphatic, cycloaliphatic or aromatic radical having 1 to 18 carbon atoms or a combination of these radicals, wherein one or more carbon atoms can be replaced by o, C═O, --o(C═O)--, SiR2 and/or NR, wherein R is an aliphatic radical having 1 to 7 carbon atoms, in which one or more carbon atoms can be replaced by o, C═O and/or --o(C═O)--, b1, b2, D and E independently of one another denote a hydrogen atom or an aliphatic radical having 1 to 9 carbon atoms, wherein one or more carbon atoms can be replaced by o, C═O, --o(C═O)--, SiR2 and/or NR, wherein R is an aliphatic radical having 1 to 7 carbon atoms, in which one or more carbon atoms can be replaced by o, C═O and/or --o(C═O)--, n denotes 2-7, m denotes 1-10, p denotes 1-5, q denotes 1-5 and x denotes CH2, S or o, (b) 0 to 80 wt. % of an epoxide or a mixture of epoxides which differ from (a), (c) 3 to 85 wt. % of fillers, (d) 0.01 to 25 wt. % of initiators and retardants or accelerators, (e) 0 to 25 wt. % of auxiliaries, the percentage data in each case being based on the total weight of the composition wherein the initiators (d) are Lewis or Broensted acids, or compounds which liberate such acids, which initiate polymerization, or substances which initiate polymerization after irradiation by UV or visible light, or by means of heat and/or pressure, in contact with a tooth.
11. An epoxide selected from the group consisting of:
i) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic acid ester]propylidene ##STR64## ii) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-oxy-methanediyl-3,4-epoxycyclohexy
l]propylidene ##STR65## iii) 2,2-bis[3,4-epoxycyclohexylmethanediyl(4,1-phenylenoxy-3,1-propylcarboxyli
c acid ester)]propylidene ##STR66## iv) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-1,1,3,3-tetramethyldisiloxanyl-1,2
-ethanediyl-3,4-epoxycyclohexyl]propylidene ##STR67## v) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propylidene ##STR68## vi) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-3,8-dioxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propylidene ##STR69## vii) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-[3,5,7-tris(ethanediyl-3,4-epoxycy
clohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]}propylidene ##STR70## viii) bis[methanediyl-oxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic acid ester]tricyclo[5.2.1.02,6 ]decane ##STR71## ix) bis[methanediyl-oxy-3,1-propanediyl-oxy-methanediyl-3,4-epoxycyclohexyl]tr
icyclo[5.2.1.02,6 ]decane ##STR72## x) bis[3,4-epoxycyclohexylmethanediyl-propanecarboxylic acid-1-oxy-methanediyl]tricyclo[5.2.1.02,6 ]decane ##STR73## xi) bis(methanediyl-oxy-3,1-propanediyl-1,1,3,3-tetramethyldisiloxanediyl-1,2-
ethanediyl-3,4-epoxycyclohexyl)tricyclo[5.2.1.02,6 ]decane ##STR74## xii) bis{methanediyl-oxy-3,1-propanediyl-3-oxatricyclo[3.2.1.02,6 ]octyl-6-carboxyl}tricyclo[5.2.1.02,6 ]decane ##STR75## xiii) bis{methanediyl-oxy-3,1-propanediyl-3,8-dioxatricyclo[3.2.1.02,6 ]octyl-6-carboxyl}tricyclo[5.2.1.02,6 ]decane ##STR76## xiv) bis(methanediyl-oxy-(3-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-epoxycycl
ohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl)-tricyclo[5.2.1.02,6 ]decane ##STR77## xv) 1,1,1-tris[methanediyl-oxy-methanediyl-3,4-epoxycyclohexyl]propane ##STR78## xvi) 1,1,1-tris[methanediyl-oxy-1,3-propanediyl-1,1,3,3-tetramethyldisiloxanedi
yl-1,2-ethanediyl-3,4-epoxycyclohexyl]propane ##STR79## xvii) 1,1,1-tris{methanediyl-3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propane ##STR80## xviii) 1,1,1-tris{methanediyl-3,8-dioxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propane ##STR81## xix) 1,1,1-tris[methanediyl-oxy-3,1-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-e
poxycyclohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]propane ##STR82## xx) 1,1,1-tris[methanediyl-oxy-bis(ethanedilyloxy)-3,4-epoxycyclohexylcarboxyl
ic acid ester]propane ##STR83## xxi) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-methanediyl-3,4-epoxycyclohe
xyl]propane ##STR84## xxii) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-propanediyl-1,1,3,3-tetramet
hyldisiloxanyl-1,2-ethanediyl-3,4-epoxycyclohexyl]propane ##STR85## xxiii) 1,1,1-tris{methanediyl-oxy-bis(ethanediyloxy)-3-oxatricyclo[3.2.1.0 2,4 ]octyl-6-carboxy}propane ##STR86## xxiv) 1,1,1-tris{methanediyl-oxy-bis(ethanediyloxy)-3,8-dioxatricyclo[3.2. 1.02,4 ]octyl-6-carboxy}propane ##STR87## xxv) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-propanediyl-3,5,7-tris(2,1-e
thanediyl-3,4-epoxycyclohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]propa
ne ##STR88## xxvi) α,ω-bis[3,4-epoxycyclohexylethanediyl-1,1,3,3-tetramethyldisil
oxanyl-3,1-propanediyl]polytetrahydrofuran ##STR89## xxvii) α,ω-bis{3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}polytetrahydrofuran ##STR90## xxviii) α,ω-bis{3,8-dioxatricyclo[3.2.1.02,4 ]octyl -6-carboxy}polytetrahydrofuran ##STR91## xxix) α,ω-bis(3-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-epoxycyclo
hexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl)polytetrahydrofuran ##STR92##
2. Polymerizable composition as claimed in patent
i) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic acid ester]propylidene ##STR35## ii) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-oxy-methanediyl-3,4-epoxycyclohexy
l]propylidene ##STR36## iii) 2,2-bis[3,4-epoxycyclohexylmethanediyl(4,1-phenylenoxy-3,1-propylcarboxyli
c acid ester)]propylidene ##STR37## iv) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-1,1,3,3-tetramethyldisiloxanyl-1,2
-ethanediyl-3,4-epoxycyclohexyl]propylidene ##STR38## v) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propylidene ##STR39## iv) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-3,8-dioxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propylidene ##STR40## vii) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-[3,5,7-tris(ethanediyl-3,4-epoxycy
clohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]}propylidene ##STR41## viii) bis[methanediyl-oxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic acid ester]tricyclo[5.2.1.02,6 ]decane ##STR42## ix) bis[methanediyl-oxy-3,1-propanediyl-oxy-methanediyl-3,4-epoxycyclohexyl]tr
icyclo[5.2.1.02,6 ]decane ##STR43## x) bis[3,4-epoxycyclohexylmethanediyl-propanecarboxylic acid-1-oxy-methanediyl]tricyclo[5.2.1.02,6 ]decane ##STR44## xi) bis(methanediyl-oxy-3,1-propanediyl-1,1,3,3-tetramethyldisiloxanediyl-1,2-
ethanediyl-3,4-epoxycyclohexyl)tricyclo[5.2.1.02,6 ]decane ##STR45## xii) bis{methanediyl-oxy-3,1-propanediyl-3-oxatricyclo[3.2.1.02,6 ]octyl-6-carboxyl}tricyclo[5.2.1.02,6 ]decane ##STR46## xiii) bis{methanediyl-oxy-3,1-propanediyl-3,8-dioxatricyclo[3.2.1.02,6 ]octyl-6-carboxyl}tricyclo[5.2.1.02,6 ]decane ##STR47## xiv) bis(methanediyl-oxy-(3-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-epoxycycl
ohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl)tricyclo[5.2.1.02,6 ]decane ##STR48## xv) 1,1,1-tris[methanediyl-oxy-methanediyl-3,4-epoxycyclohexyl]propane ##STR49## xvi) 1,1,1-tris[methanediyl-oxy-1,3-propanediyl-1,1,3,3-tetramethyldisiloxanedi
yl-1,2-ethanediyl-3,4-epoxycyclohexyl]propane ##STR50## xvii) 1,1,1-tris{methanediyl-3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propane ##STR51## xviii) 1,1,1-trist{methanediyl-3,8-dioxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propane ##STR52## xix) 1,1,1-tris[methanediyl-oxy-3,1-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-e
poxycyclohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]propane ##STR53## xx) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-3,4-epoxycyclohexylcarboxyli
c acid ester]propane ##STR54## xxi) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-methanediyl-3,4-epoxycyclohe
xyl]propane ##STR55## xxii) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-propanediyl-1,1,3,3-tetramet
hyldisiloxanyl-1,2-ethanediyl-3,4-epoxycyclohexyl]propane ##STR56## xxii) 1,1,1-tris{methanediyl-oxy-bis(ethanediyloxy)-3-oxatricyclo[3.2.1.0 2,4 ]octyl-6-carboxy}propane ##STR57## xxiv) 1,1,1-tris{methanediyl-oxy-bis(ethanediyloxy)-3,8-dioxatricyclo[3.2. 1.02,4 ]octyl-6-carboxy}propane ##STR58## xxv) 1,1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-propanediyl-3,5,7-tris(2,1
-ethanediyl-3,4-epoxycyclohexyl)-1,3,5,7-tetramethylcycloletrasiloxanyl]pro
pane ##STR59## xxvi) α,ω-bis[3,4-epoxycyclohexylethanediyl-1,1,3,3-tetramethyldisil
oxanyl-3,1-propanediyl]polytetrahydrofuran ##STR60## xxvii) α,ω-bis{3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}polytetrahydrofuran ##STR61## xxviii) α,ω-bis{3,8-dioxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}polytetrahydrofuran ##STR62## xxix) α,ω-bis(3-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-epoxycyclo
hexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl)polytetrahydrofuran ##STR63##
3. Polymerizable composition as claimed in patent
4. Polymerizable composition according to at least one of patent
5. Polymerizable composition according to at least one of patent
6. Polymerizable composition according to at least one of patent
7. Polymerizable composition according to at least
A a paste comprising the epoxides of components (a) and (b), a portion or all of the filler of component (c), if appropriate retardants or accelerators according to component (d) and if appropriate auxiliaries of component (e), and, spatially separated therefrom, b a paste comprising an initiator according to component (d), if appropriate a portion of the filler of component (c) and if appropriate auxiliaries according to component (e).
8. The polymerizable dental composition of
9. The polymerizable dental composition of
10. The polymerizable dental composition of
|
This application is the national phase under 35 U.S.C. §371 of prior PCT International Application No., PCT/EP97/06504, which has an International filing date of Nov. 21, 1997, which designated the United States of America, the entire contents of which are hereby incorporated by reference.
The invention relates to polymerizable compositions based on epoxides, new cycloaliphatic epoxides and their use.
Methacrylate and acrylate monomers have hitherto chiefly been used in polymerizable dental compositions. 2,2-Bis[4,1-phenylenoxy(2-hydroxy-3,1-propanediyl)-methacrylic acid ester]-propylidene (bis-GMA) [U.S. Pat. No. 3,066,112], described by Bowen, deserves particular attention. Mixtures of this methacrylate with triethylene glycol dimethacrylate are also used nowadays as the standard recipe for dental plastic direct filling materials. Methacryl derivatives of diformylated bis-(hydroxymethyl)tricyclo[5.2.1.02,6 ]-decane have also proved suitable as monomers for dental composites [W. Gruber et al., DE-A-27 14 538; W. Schmitt et al., DE-C-28 16 823; J. Reiners et al., EP-A-0 261 520]. A great disadvantage of the known polymerizable dental compositions is the polymerization shrinkage which, for example when they are used as filling material, can cause secondary caries due to the formation of edge gaps. Furthermore, in acrylate-based dental compositions, the polymerization inhibition by oxygen leads to the formation of a so-called greasy layer which, for example in the case of fillings, is undesirable and even harmful. Finally, acrylate-based polymerizable dental compositions have a low adhesion to the tooth substance.
Although there is extensive experience with epoxides and cycloaliphatic epoxides U.S. Pat. No. 2,716,123, U.S. Pat. No. 2,750,395, U.S. Pat. No. 2,863,881, U.S. Pat. No. 3,187,018), such monomers and cationically polymerizable compositions formulated therefrom having the properties necessary for dental uses have not been commercially available at any point in time.
The preparation of bifunctional cycloaliphatic epoxides is already described in patents from the 1950s (U.S. Pat. No. 2,750,395, U.S. Pat. No. 900,506, U.S. Pat. No. 907,149, U.S. Pat. No. 2,745,847, U.S. Pat. No. 2,853,499, U.S. Pat. No. 3,187,018, U.S. Pat. No. 2,863,881, U.S. Pat. No. 2,853,498). Silicon-containing cycloaliphatic epoxides have been described by Crivello et al. in various publications (EP-A-0 449 027; J. Polym. Sci., Part A: Polym. Chem., 28 (1990) 479, ibid. 31 (1993) 2563; ibid. 31 (1993) 2729; ibid. 31 (1993) 3109; ibid. 31 (1993) 3121; ibid. 33 (1995) 2463). The known cycloaliphatic epoxides are essentially low molecular weight monomers which indeed have a somewhat reduced polymerization shrinkage [J. Adhes. Sci. Technol. 9 (10) 1995, 1343; DE-A-4 340 949], but because of their high density of functional groups, do not meet the requirements (processing, physical properties) for dental uses.
Only little is known of cationically curable epoxide compositions for dental uses: The patent U.S. Pat. No. 5,556,896 describes epoxide-containing compositions which must necessarily comprise spiroorthocarbonates as shrinkage-compensating monomers. The company Ciba described in 1958, in the patent AT-A-204 687, epoxide dental compositions based on bisphenol A which were cured by means of Lewis acid catalysts. The long curing time and the low mechanical strength and long-term stability were problematic in these formulations. The companies Minnesota Mining and Manufacturing Company and Wictorin et al. describe in patents (WO 96/13538 and WO 95/30402) cationically curable epoxy mixtures, preferably with 3,4-epoxycyclohexyl-methyl 3,4-epoxycyclohexanecarboxylate or bis(3,4-epoxycyclohexyl adipate). This type of epoxide is highly cytotoxic and in vitro tests showed for these monomers mutagenic properties, which are undesirable in dental use.
The object of the present invention is to provide polymerizable compositions which, by comparison with the known compositions, in addition to a high reactivity and the necessary mechanical properties, have a low volume shrinkage and have no mutagenic and only mild cytotoxic properties.
According to the invention, this object is achieved by polymerizable compositions comprising
(a) 3 to 80 wt. %, preferably 3 to 75 wt. %, and in particular 5 to 70 wt. % of an epoxide or a mixture of epoxides of the general formula: ##STR1##
in which, for type A:
if n=2
Z denotes a cycloaliphatic or aromatic radical having 1 to 22, preferably 1 to 18 C atoms or a combination of these radicals, wherein one or more C atoms can be replaced by O, C═O, --O(C═O)--, SiR2 and/or NR, or an aliphatic radical having 0 to 22, preferably 1 to 18 C atoms, wherein one or more C atoms can be replaced by O, C═O, --O(C═O)--, NR or SiR2, wherein at least one C atom must be replaced by SiR2, and wherein R is an aliphatic radical having 1 to 7 C atoms, wherein one or more C atoms can be replaced by O, C═O and/or --O(C═O)--.
if n>2
Z denotes an aliphatic, cycloaliphatic or aromatic radical having 0 to 22, preferably 0 to 18 C atoms or a combination of these radicals, wherein one or more C atoms can be replaced by O, C═O, --O(C═O)--, SiR2 and/or NR and wherein R is an aliphatic radical having 1 to 7 C atoms, wherein one or more C atoms can be replaced by O, C═O and/or --O(C═O)--,
and in which, for type B:
Z denotes an aliphatic, cycloaliphatic or aromatic radical having 0 to 22, preferably 0 to 18 C atoms or a combination of these radicals, wherein one or more C atoms can be replaced by O, C═O, --O(C═O)--, SiR2 and/or NR and wherein R is an aliphatic radical having 1 to 7 C atoms, wherein one or more C atoms can be replaced by O, C═O and/or --O(C═O)--,
and in which, for type A and type B:
A denotes an aliphatic, cycloaliphatic or aromatic radical having 1 to 18, preferably 1 to 15 C atoms or a combination of these radicals, wherein one or more C atoms can be replaced by O, C═O, --O(C═O)--, SiR2 and/or NR, wherein R is an aliphatic radical having 1 to 7 C atoms, in which one or more C atoms can be replaced by O, C═O and/or --O(C═O)--,
B1, B2, D and E independently of one another denote an H atom or an aliphatic radical having 1 to 9, preferably 1 to 7 C atoms, wherein one or more C atoms can be replaced by O, C═O, --O(C═O)--, SiR2 and/or NR, wherein R is an aliphatic radical having 1 to 7 C atoms, in which one or more C atoms can be replaced by O, C═O and/or --O(C═O)--,
n denotes 2-7, preferably 2-5, in particular 2-4,
m denotes 1-10, preferably 1-7, in particular 1-5,
p denotes 1-5, preferably 1-4, in particular 1 or 2,
q denotes 1-5, preferably 1-4, in particular 1 or 2, and
x denotes CH2, S or O,
(b) 0 to 80, preferably 0 to 70 wt. % of an epoxide or a mixture of epoxides which differ from (a),
(c) 3 to 85, preferably 5 to 75 wt. % of fillers,
(d) 0.01 to 25, preferably 0.01 to 20 wt. % of initiators, retardants and/or accelerators,
(e) 0 to 25, preferably 0 to 20 wt. % of auxiliaries, the percentage data in each case being based on the total weight of the composition.
Preferred compositions according to the invention comprise, as component (a), one or more of the epoxides listed below:
i) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-3,4-epoxy-cyclohexylcarboxylic acid ester]propylidene ##STR2##
ii) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-oxy-methanediyl-3,4-epoxycyclohexy l]propylidene ##STR3##
iii) 2,2-bis[3,4-epoxycyclohexylmethanediyl(4,1-phenylenoxy-3,1-propylcarboxyli c acid ester)]propylidene ##STR4##
iv) 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-1,1,3,3-tetramethyldisiloxanyl-1,2 -ethanediyl-3,4-epoxycyclohexyl]propylidene ##STR5##
v) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propylidene ##STR6##
vi) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-3,8-dioxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propylidene ##STR7##
vii) 2,2-bis{4,1-phenylenoxy-3,1-propanediyl-[3,5,7-tris(ethanediyl-3,4-epoxycy clohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]}propylidene ##STR8##
viii) bis[methanediyl-oxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic acid ester]tricyclo[5.2.1.02,6 ]decane ##STR9##
ix) bis[methanediyl-oxy-3,1-propanediyl-oxy-methanediyl-3,4-epoxycyclohexyl]tr icyclo[5.2.1.02,6 ]decane ##STR10##
x) bis[3,4-epoxycyclohexylmethanediyl-propanecarboxylic acid-1-oxy-methanediyl]tricyclo[5.2.1.02,6 ]decane ##STR11##
xi) bis(methanediyl-oxy-3,1-propanediyl-1,1,3,3-tetramethyldisiloxanediyl-1,2- ethanediyl-3,4-epoxycyclohexyl)tricyclo[5.2.1.02,6 ]decane ##STR12##
xii) bis{methanediyl-oxy-3,1-propanediyl-3-oxatricyclo[3.2.1.02,6 ]octyl-6-carboxyl}tricyclo[5.2.1.02,6 ]decane ##STR13##
xiii) bis{methanediyl-oxy-3,1-propanediyl-3,8-dioxatricyclo[3.2.1.02,6 ]octyl-6-carboxyl}tricyclo[5.2.1.02,6 ]decane ##STR14##
xiv) bis(methanediyl-oxy-(3-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-epoxycycl ohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl)-tricyclo[5.2.1.02,6 ]decane ##STR15##
xv) 1,1,1-tris[methanediyl-oxy-methanediyl-3,4-epoxycyclohexyl]propane ##STR16##
xvi) 1,1,1-tris[methanediyl-oxy-1,3-propanediyl-1,1,3,3-tetramethyldisiloxanedi yl-1,2-ethanediyl-3,4-epoxycyclohexyl]propane ##STR17##
xvii) 1,1,1-tris{methanediyl-3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propane ##STR18##
xviii) 1,1,1-tris{methanediyl-3,8-dioxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}propane ##STR19##
xix) 1,1,1-tris[methanediyl-oxy-3,1-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-e poxycyclohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]propane ##STR20##
xx) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-3,4-epoxycyclohexylcarboxyli c acid ester]propane ##STR21##
xxi) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-methanediyl-3,4-epoxycyclohe xyl]propane ##STR22##
xxii) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-propanediyl-1,1,3,3-tetramet hyldisiloxanyl-1,2-ethanediyl-3,4-epoxycyclohexyl]propane ##STR23##
xxiii) 1,1,1-tris{methanediyl-oxy-bis(ethanediyloxy)-3-oxatricyclo[3.2.1.0 2,4 ]octyl-6-carboxy}propane ##STR24##
xxiv) 1,1,1-tris{methanediyl-oxy-bis(ethanediyloxy)-3,8-dioxatricyclo[3.2. 1.02,4 ]octyl-6-carboxy}propane ##STR25##
xxv) 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-propanediyl-3,5,7-tris(2,1-e thanediyl-3,4-epoxycyclohexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl]propa ne ##STR26##
xxvi) α,ω-bis[3,4-epoxycyclohexylethanediyl-1,1,3,3-tetramethyldisil oxanyl-3,1-propanediyl]polytetrahydrofuran ##STR27##
xxvii) α,ω-bis{3-oxatricyclo[3.2.1.02,4 ]octyl-6-carboxy}polytetrahydrofuran ##STR28##
xxviii) α,ω-bis{3,8-dioxatricyclo[3.2.1∅2,4 ]octyl-6-carboxy}polytetrahydrofuran ##STR29##
xxix) α,ω-bis(3-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-epoxycyclo hexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl)polytetrahydrofuran ##STR30##
The invention also relates to the abovementioned, individually listed new cycloaliphatic epoxides per se.
The epoxides can be prepared in a simple manner. To prepare the epoxides of type A without siloxanyl units, the cycloaliphatic alkenes obtained by conventional etherification or esterification of di-, tri- or polyols with cyclohexenecarboxylic acid or cyclohexenylmethanol are epoxidized with perbenzoic acid in suitable solvents, preferably in diethyl ether. When the reaction has ended, the mixture is washed several times with sodium hydroxide solution and dried over magnesium sulphate. The volatile constituents are distilled off in vacuo.
The epoxides of type A with siloxanyl units are prepared by two-stage conventional hydrosilylations: Compounds having two, three or more terminal alkene functions are added to an excess of a siloxane having at least two active hydrogen atoms and catalytic amounts of H2 PtCl6, dissolved in a suitable solvent (e.g. hexane). When the reaction has ended, the mixture is freed from the platinum which has precipitated out, washed once with water and dried over magnesium sulphate. In a second hydrosilylation, the resulting di-, tri- or polysiloxane-containing compound is dissolved in a suitable solvent, e.g. in toluene or alkanes, and heated with H2 PtCl6 and vinylcyclohexene epoxide. The mixture is freed from the platinum which has precipitated out and washed once with water. The product is obtained by distilling off the volatile constituents in vacuo.
To prepare epoxides of type B with terminal 3-oxatricyclo[3.2.1.02,4 ]octanyl units, di- tri- or poly(meth)acrylates are reacted with substituted (or unsubstituted) monomeric cyclopentadiene, thiophenes or furans under Lewis acid catalysis (for example ZnCl2 or AlCl3) under normal pressure or in an autoclave to give the corresponding Diels-Alder products. The endocyclic double bond is epoxidized with perbenzoic acid in a suitable solvent, preferably in diethyl ether. When the reaction has ended, the mixture is washed several times with sodium hydroxide solution and dried over magnesium sulphate. The volatile constituents are distilled off in vacuo.
In addition to the epoxides according to the invention, the polymerizable compositions according to the invention can comprise, as component (b), other low-viscosity epoxides. Low-viscosity epoxides according to (b) can be, for example: 3,4-epoxycyclohexylmethyl 3,4-epoxycyclohexanecarboxylate (U.S. Pat. No. 2,716,123), 3,4-epoxy-6-methylcyclohexyl 3,4-epoxy-6-methylcyclohexanecarboxylate (U.S. Pat. No. 2,716,123) or related epoxides, vinylcyclohexene diepoxide (U.S. Pat. No. 2,948,688), dicyclopentadiene dioxide (U.S. Pat. No. 2,985,667), bis(3,4-epoxycyclohexylmethyl) adipate (U.S. Pat. No. 2,750,395, U.S. Pat. No. 2,863,881, U.S. Pat. No. 3,187,018), 1,3,5,7-tetrakis(2,1-ethanediyl-3,4-epoxycyclohexyl)-1,3,5,7-tetramethylcy clotetrasiloxane of the following formula: ##STR31##
1,3,5,7,9-pentakis(2,1-ethanediyl-3,4-epoxycyclohexyl)-1,3,5,7,9-pentamethy lcyclopentasiloxane (U.S. Pat. No. 5,085,124) of the following formula: ##STR32##
and low molecular weight siloxanes functionalized with cycloaliphatic epoxides, for example 1,1,3,3-tetramethyl-1,3-bis(ethanediyl-3,4-epoxycyclohexyl)disiloxane (EP-A-0 449 027, EP-A-0 574 265) of the following formula: ##STR33##
The low-viscosity epoxides according to component (b) are present in a concentration of 0 to 80 wt. %, preferably 5 to 75 wt. %, in each case based on the total weight of the composition.
Inorganic fillers according to component (c) can be the customary dental fillers, for example quartz, ground, optionally X-ray-opaque, optionally reactive glasses, sparingly soluble fluorides, such as CaF2 or YF3 (EP-B-0 238 025), silica gels and pyrogenic silicic acid or granules thereof. The compositions can also comprise, as fluoride-donating constituents, one or more water-soluble inorganic complex fluorides of the general formula An MFm, wherein A denotes a mono- or polyvalent cation, M denotes a metal of main group or sub-group III, IV or V, n denotes an integer from 1 to 3 and m denotes an integer from 4 to 6 (DE-A-4 445 266). The dental compositions contain these in a concentration of 3 to 85 wt. %, preferably 5 to 75 wt. %, and in particular 30 to 75 wt. %, based on the total composition. For better incorporation into the polymer matrix, it maybe advantageous to hydrophobize the fillers and, if appropriate, the X-ray-opaque additives, such as YF3. Customary hydrophobizing agents are silanes, for example trimethoxyglycidylsilane. The maximum particle size of the inorganic fillers is preferably 20 μm, in particular 12 μm. Fillers having an average particle size <7 μm are especially preferably employed.
Initiators according to component (d) of the compositions according to the invention can be: Lewis or Broensted acids, or compounds which liberate such acids, which initiate the polymerization, for example BF3 or ether adducts thereof (BF3.THF, BF3.Et2 O, etc.), AlCl3, FeCl3, HPF6, HAsF6, HSbF6 or HBF4, or substances which initiate the polymerization after irradiation by UV or visible light or by means of heat and/or pressure, such as e.g. (eta-6-cumene)(eta-5-cyclopentadienyl)iron hexafluorophosphate, (eta-6-cumene) (eta-5-cyclopentadienyl)iron tetrafluoroborate, (eta-6-cumene)(eta-5-cyclopentadienyl)iron hexafluoroantimonate, substituted diaryliodonium salts and triarylsulphonium salts. Accelerators which can be employed are peroxy compounds of the perester, diacyl peroxide, peroxydicarbonate and hydroperoxide type. Hydroperoxides are preferably used, and cumene hydroperoxide in an approximately 70 to 90% solution in cumene is employed as the particularly preferred accelerator. The ratio of photoinitiator to cumene hydroperoxide can be varied within wide limits from 1:0.001 to 1:10, but the ratio used is preferably 1:0.1 to 1:6, and particularly preferably 1:0.5 to 1:4. The use of complexing agents, such as, for example, oxalic acid, 8-hydroxyquinoline, ethylenediaminetetraacetic acid and aromatic polyhydroxy compounds, is also possible. Retardants which can be added are bases, typically tertiary amines. Component (d) is present in the composition according to the invention in an amount of 0.01 to 25 wt. %, preferably 0.01 to 20 wt. %, based on the total weight of the composition.
Suitable auxiliaries according to component (e) can be, for example, stabilizers, pigments or diluents usually employed in the dental field.
The epoxide-containing polymerizable compositions according to the invention are particularly suitable as materials for dental purposes, for example for the production of artificial teeth or temporary prostheses, as coating compositions, for gluing substrates and as dental filling materials.
The polymerizable compositions according to the invention offer a particular advantage in dental uses. The volume shrinkage of the compositions according to the invention is far below the shrinkage of known compositions based on methacrylate monomers. As a result, for example, the edge gap problem of filling materials can be largely avoided. The dimensional stability and the storage stability of the epoxides according to the invention and of the polymerizable compositions prepared therefrom is also of great advantage in the case of precision model materials.
Compared with acrylate-based dental compositions, which have a very short setting time and therefore a sudden curing compared with epoxide-based compositions, the compositions according to the invention show a hardening which proceeds uniformly over a period of, for example, 10 to 240 seconds. Stresses within the polymers formed are thus avoided. The compositions according to the invention therefore also have an optimum processing time, before they reach their final hardness.
In addition to high compressive and flexural strengths, the polymerizable compositions according to the invention surprisingly show high impact strengths, which is of outstanding importance for dental uses.
The dental filling materials according to the invention moreover show a surprisingly good adhesion to the tooth substance. The epoxides according to the invention furthermore are not mutagenic and are acceptable in respect of their cytotoxicity.
PAC 1. Preparation of 2,2-Bis[4,1-phenylenoxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic Acid Ester]propylidene100 g 2,2-bis(4-oxypropylhydroxyphenyl)propane are kept under reflux with 85 g 4-cyclohexenecarboxylic acid in toluene for 6 hours. The solvent and excess 4-cyclohexenecarboxylic acid are distilled off. 161 g 2,2-bis(4-oxypropylphenyl-3-cyclohexenylcarboxylate)propane remain and are added to 83 g perbenzoic acid in 500 ml diethyl ether. After a reaction time of 8 hours, the mixture is washed several times with 10% sodium hydroxide solution and dried over magnesium sulphate. The volatile constituents are distilled off in vacuo.
174 g tetramethyldisiloxane are initially introduced into 800 ml hexane, and 120 mg H2 PtCl6 are added. 80 g tricyclo[5.2.1.02,6 ] decane-diallyl ether are added and the mixture is heated at 85°C (b.p.) for 3 hours. The mixture is freed from the platinum which has precipitated out, washed once with water and dried over magnesium sulphate. Hexane and volatile constituents are distilled off in vacuo. The resulting bis(tetramethyldisiloxanylpropoxymethyl)-tricyclo[5.2.1.02,6 ]decane is dissolved in 200 ml hexane, 120 mg H2 PtCl6 and 71 g vinyl-3,4-cyclohexene epoxide are added and the mixture is heated at 85°C for 3 hours. The mixture is freed from the platinum which has precipitated out, washed once with water and dried over magnesium sulphate. After the reaction mixture has been concentrated in vacuo, 202 g bis(3,4-epoxycyclohexylethyl-tetramethyldisiloxanyl-propoxymethyl)-tricycl o[5.2.1.02,6 ]decane are obtained.
126 g α,ω-polytetrahydrofuran-600-diallyl ether are added to 151 g 1,3,5,7-tetramethylcyclotetrasiloxane and 110 mg H2 PtCl6 in 700 ml hexane. After 3 hours at 85°C, the platinum which has precipitated out is separated off and all the volatile constituents are distilled off in vacuo. α,ω-Bis[3,5,7-tris(3,4-epoxycyclohexylethyl)-3-propyl-1,3,5,7- tetramethylcyclotetrasiloxanyl]-polytetrahydrofuran remains and is heated at 120°C with 179 g vinylcyclohexene epoxide and 130 mg H2 PtCl6 in 800 ml toluene for 3 hours. The platinum which has precipitated out is separated off and all the volatile constituents are distilled off in vacuo. 339 g α,ω-bis[3,5,7-tris(3,4-epoxycyclohexylethyl)-3-propyl-1,3,5,7- tetramethylcyclotetrasiloxanyl]-polytetrahydrofuran remain.
85 g α,ω-polyethylene glycol-600-dimethacrylate are heated at 120°C with 19 g furan in 300 ml toluene in an autoclave under 10 bar for 4 hours. The volatile constituents are distilled off in vacuo. α,ω-Bis(3-methyl-7-oxabicyclo[2.2. 1]heptyl-3-carboxy)polyethylene glycol remains and is added dropwise to a solution of 31 g perbenzoic acid in 300 ml diethyl ether. After a reaction time of 8 hours, the mixture is washed several times with 10% sodium hydroxide solution and dried over magnesium sulphate. The volatile constituents are distilled off in vacuo.
168 g 1,1,1-tris(methanediyl-hydroxy-bis(ethanediyloxy)]propane are initially introduced into 600 ml tetrahydrofuran. 178 g potassium tert-butanolate are added in portions and the mixture is stirred at 30°C for one hour. 277 g 3-cyclohexenylbromomethane, dissolved in 300 ml tetrahydrofuran, are then added dropwise. The reaction mixture is heated at 75°C for 24 hours. The solvent is distilled off, the mixture is suspended in methyl tert-butyl ether and the precipitate is filtered off. After aqueous extraction, 249 g 1,1,1-tris[methanediyl-oxy-bis(ethanediyloxy)-methanediyl-3-cyclohexenyl]p ropane remain and are dissolved in 500 ml diethyl ether. This solution is added to 61 g perbenzoic acid in 400 ml diethyl ether and, after a reaction time of 8 hours, the mixture is washed several times with 10% sodium hydroxide solution. The mixture is dried over magnesium sulphate and the volatile constituents are distilled off in vacuo.
1. General Preparation of Polymerizable Compositions
1.1 One-component photo- or UV-curing systems
The preparation of the one-component compositions which can be polymerized according to the invention is a two-stage process in which homogeneous premixing of all the constituents with the exception of the photoinitiator takes place in the first stage. In a second stage, the photoinitiator is kneaded homogeneously into the paste with exclusion of light. When the epoxy resins according to the invention which have been obtained in this way and can be processed have been mixed in completely, they are introduced into light-proof containers.
1.2 Two-component systems
The two-component compositions which can be polymerized according to the invention are prepared by first preparing a homogeneously mixed component A comprising the epoxide monomers, a filler content, the retardants, accelerators and the auxiliaries. A homogeneously mixed component B comprising the initiator, diluent and a further filler content is furthermore prepared. Components A and B are introduced, for example, into a double-cartridge system. The two-component composition can be processed directly by a static mixer on the cartridge system.
2. Use Examples
Component A: A paste is kneaded from 17.6 parts by wt. α,ω-bis(3-propanediyl-3,5,7-tris(2,1-ethanediyl-3,4-epoxycyclo hexyl)-1,3,5,7-tetramethylcyclotetrasiloxanyl)-ditetrahydrofuran, 17.6 parts by wt. 3,4-epoxycyclohexylmethyl 3,4-epoxycyclohexanecarboxylate and 64.7 parts by wt. of a silanized, pigmented quartz. A second component B comprises 32.8 parts by wt. polyethylene glycol, 4.7 parts by wt. BF3.OEt2 and 62.5 parts by wt. of a silanized pigmented quartz. Pastes A and B are mixed in a ratio of 2:1 via a static mixer. The composition cures within two minutes.
A paste is kneaded from 18 parts by wt. bis(methanediyl-oxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic acid ester)-tricyclo[5.2.1.02,6 ]decane, 10 parts by wt. 1,1,3,3-tetramethyl-1,3-bis(ethanediyl-3,4-epoxycyclohexyl)disiloxane, 68.9 parts by wt. of a silanized pigmented quartz, 1.2 parts by wt. (eta-6-cumene)(eta-5-cyclopentadienyl)iron hexafluorophosphate and 1.8 parts by wt. cumene hydroperoxide and is cured by irradiation with a lamp (Elipar II light apparatus, ESPE Dental-Medizin GmbH & Co. KG, Germany) in the course of approx. 40 seconds.
16.7 parts by wt. 1,1,1-tris[methanediyl-oxy-1,3-propanediyl-1,1,3,3-tetramethyldisiloxanedi yl-1,2-ethanediyl-3,4-epoxycyclohexyl]propane, 4.5 parts by wt. 3,4-epoxycylcohexylmethyl 3,4-epoxycyclohexanecarboxylate, 5.2 parts by wt. 1,3,5,7-tetrakis(2,1-ethanediyl-3,4-epoxycyclohexyl)-1,3,5,7-tetramethylcy clotetrasiloxane, 70.5 parts by wt. of a silanized pigmented quartz, 1.2 parts by wt. (eta-6-cumene)(eta-5-cyclopentadienyl)iron hexafluorophosphate and 1.9 parts by wt. cumene hydroperoxide are kneaded to a paste, which is cured by irradiation with a lamp (Elipar II light apparatus, ESPE Dental-Medizin GmbH & Co. KG, Germany) in the course of approx. 40 seconds.
18 parts by wt. 2,2-bis[4,1-phenylenoxy-3,1-propanediyl-3,4-epoxycyclohexylcarboxylic acid ester]propylidene, 13 parts by wt. 3,4-epoxycyclohexylmethyl 3,4-epoxycyclohexanecarboxylate, 65.4 parts by wt. of a silanized pigmented quartz, 1.5 parts by wt. (eta-6-cumene)(eta-5-cyclopentadienyl)iron hexafluorophosphate and 2.1 parts by wt. cumene hydroperoxide are kneaded to a paste, which is cured by irradiation with a lamp (Elipar II light apparatus, ESPE Dental-Medizin GmbH & Co. KG, Germany) in the course of approx. 40 seconds.
Comparison paste, commercially obtainable dental composition
TBL Ex- Ex- Ex- Ex- Ex- ample ample ample ample ample 5 (comp- 1 2 3 4 arison) Compressive 388 331 361 355 385 strength [MPa] Flexural strength 151 131 121 141 118 [MPa] (ISO 4049) Volume shrinkage [%] 1.3 0.8 0.7 1.0 2.2Guggenberger, Rainer, Gasser, Oswald, Zech, Joachim, Lechner, Gunther, Soglowek, Wolfgang, Weinmann, Wolfgang
Patent | Priority | Assignee | Title |
10398532, | Dec 30 2010 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Bondable dental assemblies and methods including a compressible material |
10492890, | Oct 23 2006 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Assemblies, methods, and kits including a compressible material |
11471255, | Dec 30 2010 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Bondable dental assemblies and methods including a compressible material |
11839521, | Oct 23 2006 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Assemblies, methods, and kits including a compressible material |
11992538, | Aug 19 2019 | VOCO GmbH | Polymerizable dental composition based on condensed silanes |
6362251, | Oct 09 1998 | DEGUDENT GMBH | Dental material comprising porous glass ceramics, porous glass ceramics, processes and use |
6465541, | Oct 07 1998 | 3M Innovative Properties Company | Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same |
6613437, | Mar 18 1999 | 3M Deutschland GmbH | Two-component preparations containing epoxy compounds |
6613438, | Jan 28 1999 | Siemens Aktiengesellschaft | Single component adhesive with an adaptable open joint time |
6747071, | Oct 02 1998 | Bluestar Silicones France SAS | Dental composition based on silicone crosslinkable by cation process |
6779656, | Jan 13 2000 | 3M Innovative Properties Company | Polymerizable preparations based on epoxides that contain silicon |
6908953, | Sep 21 1998 | 3M Deutschland GmbH | Polymerizable compositions based on epoxides |
7030049, | Oct 07 1998 | 3M Innovative Properties Company | Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same |
7160528, | Oct 07 1998 | 3M Innovative Properties Company | Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same |
7235602, | Feb 19 2001 | 3M Deutschland GmbH | Polymerizable preparations on the basis of silicon compounds comprising aliphatic and cycloaliphatic epoxide groups |
7247660, | Jun 25 2001 | Bluestar Silicones France SAS | Dental composition based on silicone crosslinkable by cation process |
7368524, | Apr 30 2004 | 3M Deutschland GmbH | Cationically curing two component materials containing a noble metal catalyst |
7576144, | Jul 14 2004 | 3M Innovative Properties Company | Dental compositions containing carbosilane monomers |
7662869, | Jul 14 2004 | 3M Deutschland GmbH | Dental composition containing unsaturated carbosilane containing components |
7740482, | May 13 2004 | Bluestar Silicones France SAS | Stable cationically crosslinkable/polymerizable dental composition with a high filler content |
7776940, | Dec 20 2005 | 3M Innovative Properties Company | Methods for reducing bond strengths, dental compositions, and the use thereof |
7816422, | Sep 21 2005 | FUJIFILM Corporation | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate |
7893130, | May 13 2004 | Bluestar Silicones France SAS | Photocurable dental composition |
7896650, | Dec 20 2005 | 3M Innovative Properties Company | Dental compositions including radiation-to-heat converters, and the use thereof |
7915324, | Jul 14 2004 | 3M Innovative Properties Company | Dental composition containing unsaturated carbosilane containing components |
7927538, | Jul 30 2008 | Technische Universitat Wien | Light-curing slips for the stereolithographic preparation of dental ceramics |
8003711, | Jul 14 2004 | 3M Deutschland GmbH | Dental composition containing Si-H functional carbosilane components |
8026296, | Dec 20 2005 | 3M Innovative Properties Company | Dental compositions including a thermally labile component, and the use thereof |
8084515, | Jul 14 2004 | 3M Innovative Properties Company | Dental compositions containing carbosilane polymers |
8163426, | Jan 25 2008 | Samsung SDI Co., Ltd. | Polysiloxane-based compound for electrolyte of lithium secondary battery, organic electrolyte solution including the polysiloxane-based compound, and lithium battery using the solution |
8222348, | Apr 17 2007 | Asahi Kasei Chemicals Corporation | Epoxy silicone and process for producing same, and curable mix composition using same and use thereof |
8226737, | Jul 03 2008 | 3M Innovative Properties Company | Fixed abrasive particles and articles made therefrom |
8262391, | Oct 02 1998 | Bluestar Silicones France SAS | Dental composition based on silicone crosslinkable by cation process |
8314162, | Jun 10 2008 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Initiator system containing a diarylalkylamine derivate, hardenable composition and use thereof |
8389599, | Oct 22 2008 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Dental composition comprising biphenyl di(meth)acrylate monomer comprising urethane moieties |
8519019, | Dec 18 2001 | Bluestar Silicones France SAS | Dental composition based on a colloidal silica solution in a continuous silicon phase |
9078836, | May 11 2012 | Shin-Etsu Chemical Co., Ltd. | Block type-modified organopolysiloxane, method for using the organopolysiloxane, cosmetic, and method for producing the organopolysiloxane |
9249256, | Sep 14 2011 | DAICEL CORPORATION | Triepoxy compound and method for producing same |
9351908, | Oct 01 2007 | 3M Innovative Properties Company | Orthodontic composition with polymeric fillers |
9480540, | Dec 30 2010 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Bondable dental assemblies and methods including a compressible material |
9539065, | Oct 23 2006 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Assemblies, methods, and kits including a compressible material |
9540488, | Dec 16 2015 | Industrial Technology Research Institute | Siloxane resin composition, and photoelectric device employing the same |
9856347, | Feb 28 2014 | DAICEL CORPORATION | Curable composition, cured product thereof, and wafer level lens |
Patent | Priority | Assignee | Title |
3449274, | |||
3956317, | Feb 13 1970 | Ciba-Geigy AG | Diepoxides, processes for their manufacture and use |
4279717, | Aug 03 1979 | General Electric Company | Ultraviolet curable epoxy silicone coating compositions |
4576999, | May 06 1982 | General Electric Company | Ultraviolet radiation-curable silicone release compositions with epoxy and/or acrylic functionality |
5260349, | Jan 04 1991 | Polyset Corporation | Electron beam curable epoxy compositions |
5556896, | Jul 01 1993 | CURATORS OF THE UNIVERSITY OF MISSOURI, THE | Polymeric compositions and composites prepared from spiroortho-carbonates and epoxy monomers |
DE19534668A1, | |||
DE3038153A1, | |||
DE4133494A1, | |||
DE4324322A1, | |||
DE4405148C1, | |||
DE4421623A1, | |||
EP3810096, | |||
EP434010A1, | |||
EP524524A1, | |||
EP532896A2, | |||
EP748831A2, | |||
EP20394192, | |||
WO9530402, | |||
WO9613538, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 16 1998 | WEINMANN, WOLFGANG | ESPE Dental AG | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 009464 | /0374 | |
Jul 16 1998 | GASSER, OSWALD | ESPE Dental AG | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 009464 | /0374 | |
Jul 16 1998 | GUGGENBERGER, RAINER | ESPE Dental AG | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 009464 | /0374 | |
Jul 16 1998 | LECHNER, GUNTHER | ESPE Dental AG | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 009464 | /0374 | |
Jul 16 1998 | SOGLOWEK, WOLFGANG | ESPE Dental AG | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 009464 | /0374 | |
Jul 16 1998 | ZECH, JOACHIM | ESPE Dental AG | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 009464 | /0374 | |
Sep 21 1998 | ESPE Dental AG | (assignment on the face of the patent) | / | |||
Mar 22 2001 | ESPE Dental AG | 3M ESPE AG | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 013578 | /0031 | |
Dec 23 2011 | 3M ESPE AG | 3M Deutschland GmbH | MERGER SEE DOCUMENT FOR DETAILS | 027762 | /0754 |
Date | Maintenance Fee Events |
Mar 26 2002 | ASPN: Payor Number Assigned. |
Dec 13 2004 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Dec 12 2008 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Oct 01 2012 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Jun 12 2004 | 4 years fee payment window open |
Dec 12 2004 | 6 months grace period start (w surcharge) |
Jun 12 2005 | patent expiry (for year 4) |
Jun 12 2007 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 12 2008 | 8 years fee payment window open |
Dec 12 2008 | 6 months grace period start (w surcharge) |
Jun 12 2009 | patent expiry (for year 8) |
Jun 12 2011 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 12 2012 | 12 years fee payment window open |
Dec 12 2012 | 6 months grace period start (w surcharge) |
Jun 12 2013 | patent expiry (for year 12) |
Jun 12 2015 | 2 years to revive unintentionally abandoned end. (for year 12) |